GAITHERSBURG, Md., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) will release its financial results for the third quarter and nine months of 2017 immediately after market close on Thursday, November 2, 2017. The company will also host a conference call at 5:00 pm (Eastern Time) at which time members of management will discuss these results, as well as recent business developments, revenue and net income guidance for full year 2017 and revenue guidance for fourth quarter 2017.
This conference call can be accessed live by telephone or via webcast:
Top Company Interviews
Live Teleconference Information:
Dial in number: (855) 766-6521
Conference ID: 29706026Live Webcast Information:
Visit https://edge.media-server.com/m6/p/dvysvtww for the live webcast feed.
A replay of the call can be accessed on Emergent's website emergentbiosolutions.com under 'Investors.'
About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally emerging public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at emergentbiosolutions.com. Follow us @emergentbiosolu.
Investor Contact:Robert G. Burrows
Vice President, Investor Relations
240-631-3280 BurrowsR@ebsi.comMedia Contact:Lynn Kieffer
Vice President, Corporate Communications
Emergent Biosolutions, Inc.
Emergent BioSolutions Inc. published this content on 19 October 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 19 October 2017 11:16:10 UTC.